Skip to main content

KalVista Pharmaceuticals, Inc.

KALVDelisted Jun 11, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001348911

KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.

13F holders, Q3 2023

Institutional positions in KalVista Pharmaceuticals, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
101
+7 vs. Q2 2023
Shares held
36.3M
+1.81M (+5.3%) vs. Q2 2023
Total value
$349.2M
+$39.2M (+12.6%) vs. Q2 2023
New holders
17
34 more added
Sold out
10
27 more reduced

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting KALV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 101 institutions
Q1 2021: 117 institutionsQ2 2021: 110 institutionsQ3 2021: 105 institutionsQ4 2021: 97 institutionsQ1 2022: 89 institutionsQ2 2022: 91 institutionsQ3 2022: 94 institutionsQ4 2022: 91 institutionsQ1 2023: 88 institutionsQ2 2023: 94 institutionsQ3 2023: 101 institutionsQ4 2023: 93 institutionsQ1 2024: 129 institutionsQ2 2024: 119 institutionsQ3 2024: 122 institutionsQ4 2024: 130 institutionsQ1 2025: 128 institutionsQ2 2025: 140 institutionsQ3 2025: 145 institutionsQ4 2025: 162 institutionsQ1 2026: 184 institutionsQ2 2026: 1 institution
Value heldQ3 2023: $349.2M
Q1 2021: $605.1MQ2 2021: $582.7MQ3 2021: $408.2MQ4 2021: $314.6MQ1 2022: $363.9MQ2 2022: $238.7MQ3 2022: $372.0MQ4 2022: $236.2MQ1 2023: $265.0MQ2 2023: $310.1MQ3 2023: $349.2MQ4 2023: $453.0MQ1 2024: $557.2MQ2 2024: $568.2MQ3 2024: $561.0MQ4 2024: $467.4MQ1 2025: $633.7MQ2 2025: $615.5MQ3 2025: $714.0MQ4 2025: $1.08BQ1 2026: $1.39BQ2 2026: $189
Institutions holding KALV and their total value by quarter
QuarterHoldersValue
Q2 20261$189
Q1 2026184$1.39B
Q4 2025162$1.08B
Q3 2025145$714.0M
Q2 2025140$615.5M
Q1 2025128$633.7M
Q4 2024130$467.4M
Q3 2024122$561.0M
Q2 2024119$568.2M
Q1 2024129$557.2M
Q4 202393$453.0M
Q3 2023101$349.2M
Q2 202394$310.1M
Q1 202388$265.0M
Q4 202291$236.2M
Q3 202294$372.0M
Q2 202291$238.7M
Q1 202289$363.9M
Q4 202197$314.6M
Q3 2021105$408.2M
Q2 2021110$582.7M
Q1 2021117$605.1M

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding KalVista Pharmaceuticals, Inc.; share changes are against Q2 2023.

Institutions holding KALV in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Tang Capital Management LLC3,440,345$33.1M4.67%+788,952+29.8%Added
Commodore Capital LP0$00.00%−312,553−100.0%Sold out
Woodline Partners LP0$00.00%−108,358−100.0%Sold out
Los Angeles Capital Management LLC0$00.00%−72,540−100.0%Sold out
HighVista Strategies LLC0$00.00%−69,567−100.0%Sold out
Denali Advisors LLC0$00.00%−29,200−100.0%Sold out
Millennium Management LLC0$00.00%−27,935−100.0%Sold out
Acadian Asset Management LLC0$00.00%−8,736−100.0%Sold out
Russell Investments Group, Ltd.0$00.00%−1,004−100.0%Sold out
Crewe Advisors LLC0$00.00%−14−100.0%Sold out
Sofos Investments, Inc.0$00.00%−9−100.0%Sold out